INMED PHARMACEUTICALS INC. Variable Lease, Cost
INMED PHARMACEUTICALS INC. (INM) reported Variable Lease, Cost of $79.90 thousand for the 6-month period ending 2021-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2022-02-14
- INMED PHARMACEUTICALS INC. variable lease, cost for the quarter ending 2021-12-31 was $18.29K.
- INMED PHARMACEUTICALS INC. variable lease, cost for the quarter ending 2021-09-30 was $61.62K.
- INMED PHARMACEUTICALS INC. variable lease, cost for the quarter ending 2021-06-30 was $911.00.
- INMED PHARMACEUTICALS INC. variable lease, cost for the quarter ending 2021-03-31 was $767.00.
- INMED PHARMACEUTICALS INC. variable lease, cost for fiscal 2021 was $63.33K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2021-12-31 | $18.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $79.90K 10-Q · filed 2022-02-14 | $80.81K derived: sum of 3 quarters · filed 2022-02-14 | $81.58K derived: sum of 4 quarters · filed 2022-02-14 |
| 2021-09-30 | $61.62K 10-Q · filed 2021-11-10 | $62.53K derived: sum of 2 quarters · filed 2021-11-10 | $63.29K derived: sum of 3 quarters · filed 2021-11-10 | |
| 2021-06-30 | $911.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-24 | $1.68K derived: sum of 2 quarters · filed 2021-09-24 | $63.33K 10-K · filed 2021-09-24 | |
| 2021-03-31 | $767.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $62.42K 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | $61.66K 10-Q · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |